Annual Current Liabilities
$31.55 M
+$8.37 M+36.14%
31 December 2023
Summary:
Lexicon Pharmaceuticals annual total current liabilities is currently $31.55 million, with the most recent change of +$8.37 million (+36.14%) on 31 December 2023. During the last 3 years, it has fallen by -$15.26 million (-32.60%). LXRX annual current liabilities is now -80.84% below its all-time high of $164.64 million, reached on 31 December 2016.LXRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$36.05 M
+$8.17 M+29.31%
30 September 2024
Summary:
Lexicon Pharmaceuticals quarterly total current liabilities is currently $36.05 million, with the most recent change of +$8.17 million (+29.31%) on 30 September 2024. Over the past year, it has increased by +$3.79 million (+11.73%). LXRX quarterly current liabilities is now -78.81% below its all-time high of $170.11 million, reached on 30 September 2016.LXRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXRX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.1% | +11.7% |
| 3 y3 years | -32.6% | +5.3% |
| 5 y5 years | -14.2% | -19.6% |
LXRX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -32.6% | +42.6% | at high | +113.8% |
| 5 y | 5 years | -51.7% | +42.6% | -63.0% | +113.8% |
| alltime | all time | -80.8% | +197.5% | -78.8% | +437.3% |
Lexicon Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $36.05 M(+29.3%) |
| June 2024 | - | $27.88 M(+19.1%) |
| Mar 2024 | - | $23.40 M(-25.8%) |
| Dec 2023 | $31.55 M(+36.1%) | $31.55 M(-2.2%) |
| Sept 2023 | - | $32.26 M(+23.6%) |
| June 2023 | - | $26.11 M(+28.2%) |
| Mar 2023 | - | $20.37 M(-12.1%) |
| Dec 2022 | $23.17 M(+4.7%) | $23.17 M(+25.6%) |
| Sept 2022 | - | $18.45 M(+9.4%) |
| June 2022 | - | $16.86 M(-10.8%) |
| Mar 2022 | - | $18.91 M(-14.5%) |
| Dec 2021 | $22.12 M(-52.7%) | $22.12 M(-35.4%) |
| Sept 2021 | - | $34.25 M(+4.4%) |
| June 2021 | - | $32.81 M(-15.8%) |
| Mar 2021 | - | $38.99 M(-16.7%) |
| Dec 2020 | $46.81 M(-28.4%) | $46.81 M(-40.7%) |
| Sept 2020 | - | $78.92 M(-19.1%) |
| June 2020 | - | $97.56 M(+21.5%) |
| Mar 2020 | - | $80.32 M(+22.9%) |
| Dec 2019 | $65.34 M(+77.8%) | $65.34 M(+45.8%) |
| Sept 2019 | - | $44.82 M(+99.5%) |
| June 2019 | - | $22.47 M(-20.4%) |
| Mar 2019 | - | $28.22 M(-23.2%) |
| Dec 2018 | $36.75 M(-65.2%) | $36.75 M(-46.4%) |
| Sept 2018 | - | $68.51 M(-15.8%) |
| June 2018 | - | $81.34 M(-19.0%) |
| Mar 2018 | - | $100.37 M(-4.9%) |
| Dec 2017 | $105.49 M(-35.9%) | $105.49 M(-18.1%) |
| Sept 2017 | - | $128.73 M(-3.3%) |
| June 2017 | - | $133.17 M(-2.8%) |
| Mar 2017 | - | $137.06 M(-16.8%) |
| Dec 2016 | $164.64 M(+33.9%) | $164.64 M(-3.2%) |
| Sept 2016 | - | $170.11 M(+29.9%) |
| June 2016 | - | $130.99 M(+7.4%) |
| Mar 2016 | - | $121.94 M(-0.8%) |
| Dec 2015 | $122.96 M(+173.4%) | $122.96 M(+137.4%) |
| Sept 2015 | - | $51.80 M(+18.9%) |
| June 2015 | - | $43.57 M(-5.1%) |
| Mar 2015 | - | $45.93 M(+2.1%) |
| Dec 2014 | $44.97 M(+133.1%) | $44.97 M(+1.6%) |
| Sept 2014 | - | $44.27 M(+102.2%) |
| June 2014 | - | $21.90 M(+23.9%) |
| Mar 2014 | - | $17.67 M(-8.4%) |
| Dec 2013 | $19.29 M(+5.5%) | $19.29 M(-18.2%) |
| Sept 2013 | - | $23.60 M(-42.3%) |
| June 2013 | - | $40.90 M(+135.3%) |
| Mar 2013 | - | $17.38 M(-4.9%) |
| Dec 2012 | $18.29 M | $18.29 M(-4.0%) |
| Sept 2012 | - | $19.05 M(-11.6%) |
| June 2012 | - | $21.55 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $20.93 M(-2.1%) |
| Dec 2011 | $21.39 M(+98.5%) | $21.39 M(+44.5%) |
| Sept 2011 | - | $14.81 M(+11.9%) |
| June 2011 | - | $13.23 M(-8.7%) |
| Mar 2011 | - | $14.48 M(+34.4%) |
| Dec 2010 | $10.78 M(-78.9%) | $10.78 M(-16.8%) |
| Sept 2010 | - | $12.95 M(-52.8%) |
| June 2010 | - | $27.45 M(-42.0%) |
| Mar 2010 | - | $47.32 M(-7.1%) |
| Dec 2009 | $50.95 M(+140.6%) | $50.95 M(+1.6%) |
| Sept 2009 | - | $50.17 M(+306.2%) |
| June 2009 | - | $12.35 M(+0.6%) |
| Mar 2009 | - | $12.28 M(-42.0%) |
| Dec 2008 | $21.18 M(-40.1%) | $21.18 M(-15.3%) |
| Sept 2008 | - | $25.01 M(-9.6%) |
| June 2008 | - | $27.66 M(-0.1%) |
| Mar 2008 | - | $27.69 M(-21.7%) |
| Dec 2007 | $35.35 M(-23.1%) | $35.35 M(-5.4%) |
| Sept 2007 | - | $37.34 M(-5.4%) |
| June 2007 | - | $39.49 M(-8.5%) |
| Mar 2007 | - | $43.16 M(-6.1%) |
| Dec 2006 | $45.97 M(-20.0%) | $45.97 M(-4.7%) |
| Sept 2006 | - | $48.22 M(-11.5%) |
| June 2006 | - | $54.49 M(-1.8%) |
| Mar 2006 | - | $55.49 M(-3.4%) |
| Dec 2005 | $57.46 M(+48.4%) | $57.46 M(+18.9%) |
| Sept 2005 | - | $48.32 M(+25.1%) |
| June 2005 | - | $38.64 M(+17.3%) |
| Mar 2005 | - | $32.95 M(-14.9%) |
| Dec 2004 | $38.71 M(+21.9%) | $38.71 M(+20.5%) |
| Sept 2004 | - | $32.13 M(+17.4%) |
| June 2004 | - | $27.36 M(-0.6%) |
| Mar 2004 | - | $27.53 M(-13.3%) |
| Dec 2003 | $31.77 M(+49.1%) | $31.77 M(+40.2%) |
| Sept 2003 | - | $22.65 M(-5.4%) |
| June 2003 | - | $23.94 M(+42.6%) |
| Mar 2003 | - | $16.79 M(-21.2%) |
| Dec 2002 | $21.30 M(+13.4%) | $21.30 M(+22.8%) |
| Sept 2002 | - | $17.35 M(-5.7%) |
| June 2002 | - | $18.39 M(+1.2%) |
| Mar 2002 | - | $18.17 M(-3.2%) |
| Dec 2001 | $18.78 M(+67.2%) | $18.78 M(-0.7%) |
| Sept 2001 | - | $18.92 M(-11.8%) |
| June 2001 | - | $21.45 M(+99.1%) |
| Mar 2001 | - | $10.77 M(-4.1%) |
| Dec 2000 | $11.23 M(+5.9%) | $11.23 M(+67.4%) |
| Sept 2000 | - | $6.71 M(-29.8%) |
| June 2000 | - | $9.55 M(-11.4%) |
| Mar 2000 | - | $10.78 M |
| Dec 1999 | $10.60 M | - |
FAQ
- What is Lexicon Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals annual current liabilities year-on-year change?
- What is Lexicon Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals quarterly current liabilities year-on-year change?
What is Lexicon Pharmaceuticals annual total current liabilities?
The current annual current liabilities of LXRX is $31.55 M
What is the all time high annual current liabilities for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high annual total current liabilities is $164.64 M
What is Lexicon Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, LXRX annual total current liabilities has changed by +$8.37 M (+36.14%)
What is Lexicon Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of LXRX is $36.05 M
What is the all time high quarterly current liabilities for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high quarterly total current liabilities is $170.11 M
What is Lexicon Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, LXRX quarterly total current liabilities has changed by +$3.79 M (+11.73%)